BIIB
Biogen Idec Inc.
Industry: Biotechnology Exchange: U.S.: Nasdaq
Last Trade
4:20 PM
5/21/2013
225.184:20 PM
5/21/2013
-1.67 (-0.74%)
1,262,772 Volume: |
1,587,000 Avg Volume: |
|
234.46 52-wk High: |
126.39 52-wk Low: |
|
234.46 Day's High: |
224.33 Day's Low: |
|
NA Dividend: |
226.85 Prev. Close |
|
NA Yield: |
$39,866 mil Market Value: |
|
29.3 P/E (Trailing): |
23.6% 5-Year EPS Growth Rate |
|
176,054.10 Liquidity Ratio |
93.4% % Owned by Institutions |
|
236,312,000 Shares Outstanding |
||
Company Information
(781) 464-2000 Phone Number |
NA CEO |
| Address: 133 Boston Post Road, Weston, Massachusetts 02493 |
| Sector SPDR |
| Description: Biogen Idec, Inc. is a global biotechnology company focused on discovering, developing, manufacturing and marketing therapies for the treatment of multiple sclerosis (MS) and other autoimmune disorders, neurodegenerative diseases and hemophilia. |
Current News
